Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Cancer Causes Control. 2012 Jun 2;23(8):1241–1251. doi: 10.1007/s10552-012-0002-2

Table 5.

Estimated hazard ratios for the effects of each MetS component examined on breast cancer risk among 8,956 participants from the Study of Osteoporotic Fracturesa

Model 1b Model 2c

Hazard Ratio 95% Confidence Interval P value Hazard Ratio 95% Confidence Interval P value
All breast cancers
 Waist circumference ≥ 88 cm 1.18 0.97, 1,44 0.10 0.90 0.69, 1.18 0.44
 Diabetes 1.29 0.90, 1.85 0.16 1.21 0.84, 1.76 0.30
 Hypertension 1.05 0.86, 1.29 0.61 1.01 0.82, 1.24 0.93

Invasive only
 Waist circumference ≥ 88 cm 1.18 0.95, 1.48 0.14 0.89 0.66, 1.20 0.43
 Diabetes 1.27 0.85, 1.91 0.24 1.18 0.77, 1.80 0.44
 Hypertension 0.96 0.77, 1.21 0.74 0.92 0.73, 1.15 0.46

ER Positived
 Waist circumference ≥ 88 cm 1.30 1.03, 1.66 0.03 0.91 0.66, 1.26 0.57
 Diabetes 1.47 0.98, 2.21 0.07 1.35 0.88, 2.06 0.17
 Hypertension 1.06 0.83, 1.37 0.63 1.00 0.78, 1.29 0.99

PR Positived
 Waist circumference ≥ 88 cm 1.51 1.16, 1.97 <0.01 0.93 0.65, 1.34 0.70
 Diabetes 1.50 0.95, 2.37 0.08 1.34 0.83, 2.17 0.22
 Hypertension 0.96 0.73, 1.27 0.79 0.89 0.67, 1.18 0.42
a

Hazard ratios are reported for waist circumference ≥88cm vs. waist circumference <88cm, diabetes vs. no diabetes, and hypertension vs. no hypertension

b

Model 1 adjusts for age, current hormone use, family history of breast cancer, and other MetS criteria (e.g. waist circumference adjusted for diabetes and hypertension)

c

Model 2 adjusts for BMI in addition to variables included in Model 1

d

Includes invasive cases only